MK-2828

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Chronic Kidney FailureDiabetes Mellitus, Type 2End-Stage Renal DiseaseHealthyRenal Impairment

Phase 1

Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

CompletedNCT07089784

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2025-09-22End: 2026-05-04Updated: 2026-05-22

A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)

CompletedNCT07348237

Merck Sharp & Dohme LLCChronic Kidney Failure, End-Stage Renal Disease, Renal Impairment

Start: 2026-03-02End: 2026-09-01Updated: 2026-09-15

A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)

CompletedNCT07431866

Merck Sharp & Dohme LLCHealthy

Start: 2026-03-18End: 2026-06-13Updated: 2026-09-08

A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)

CompletedNCT07435194

Merck Sharp & Dohme LLCHealthy

Start: 2026-03-06End: 2026-08-17Updated: 2026-09-08